Johnson & Johnson (JNJ) Accumulated Expenses (2009 - 2026)

Johnson & Johnson has disclosed Accumulated Expenses across 18 years of filings, most recently posting $9.5 billion for Q2 2026.

• In Q2 2026, Accumulated Expenses rose 27.82% year-over-year to $9.5 billion; the TTM figure through Jun 2026 stood at $9.5 billion (up 27.82% YoY), while the FY2025 annual figure was $8.6 billion, up 0.53% from the prior year.
• Accumulated Expenses came in at $9.5 billion for Q2 2026 at Johnson & Johnson, up from $7.4 billion in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $13.6 billion in Q1 2022 to a low of $7.4 billion in Q1 2026.
• Average Accumulated Expenses over 5 years is $10.2 billion, with a median of $10.3 billion recorded in 2024.
• Year-over-year, Accumulated Expenses tumbled 33.62% in 2025 and gained 27.82% in 2026.
• Over 5 years, Accumulated Expenses stood at $12.0 billion in 2022, then dropped by 14.57% to $10.2 billion in 2023, then dropped by 16.28% to $8.5 billion in 2024, then climbed by 0.53% to $8.6 billion in 2025, then increased by 10.12% to $9.5 billion in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $9.5 billion in Q2 2026, $7.4 billion in Q1 2026, and $8.6 billion in Q4 2025.